The Association of Criminal Justice Supervision Setting with Overdose Mortality: a Longitudinal Cohort Study

Overview

Journal Addiction

Specialty Psychiatry

Date 2020 Apr 9

PMID 32267585

Citations 14

Authors

Ingrid A Binswanger

Anh P Nguyen

Jeffrey D Morenoff

Stanley Xu

David J Harding

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Despite the high prevalence of substance use among people in the US criminal justice system, little is known about the incidence of overdose mortality by use patterns, drug convictions and supervision setting. We examined the associations between these characteristics and overdose mortality.

Design: Retrospective cohort study.

Setting And Participants: Individuals sentenced to prison, jail, probation or jail plus probation for a felony conviction in Michigan, USA from 2003 to 2006.

Measurements: Using the National Death Index, we assessed overdose mortality to December 2012. We calculated overdose mortality rates by pre-sentence opioid use, drug convictions and supervision setting. Multivariable analyses were conducted using competing risks regression with time-varying covariates.

Findings: Among 140 266 individuals followed over a mean of 7.84 years [standard deviation (SD) = 1.52], 14.9% of the 1131 deaths were due to overdose (102.8 per 100 000 person-years). Over the follow-up, more than half of overdose deaths occurred in the community (57.7%), nearly a third (28.8%) on probation and 12.8% on parole. The adjusted risk of overdose death was lower on probation [hazard ratio (HR) = 0.71, 95% confidence interval (CI) = 0.60, 0.85] than in the community without probation or parole (HR = 1.00) but not significantly different on parole (HR = 1.13, 95% CI = 0.87, 1.47). Pre-sentence daily opioid use (HR = 3.54, 95% CI = 3.24, 3.87) was associated with an increased risk. Drug possession (HR = 1.11, 95% CI = 0.93, 1.31) and delivery convictions (HR = 0.92, 95% CI = 0.77, 1.09) were not significantly associated with overdose mortality.

Conclusions: Based on the absolute or relative risk, parole, probation and community settings are appropriate settings for enhanced overdose prevention interventions. Ensuring that individuals with pre-sentence opioid use have access to harm reduction and drug treatment services may help to prevent overdose among people involved with the criminal justice system.

Citing Articles

Extended-release buprenorphine induction in opioid non-tolerant incarcerated individuals.

Gordon M, Blue T, Vocci F, Mitchell S, Wenzel K, Fishman M Drug Alcohol Depend Rep. 2025; 12():100261.

PMID: 39829944 PMC: 11740793. DOI: 10.1016/j.dadr.2024.100261.

Description of implementing a mail-based overdose education and naloxone distribution program in community supervision settings during COVID-19.

Oser C, McGladrey M, Oyler D, Knudsen H, Walsh S, Stitzer S J Subst Use Addict Treat. 2025; 170:209618.

PMID: 39743179 PMC: 11885019. DOI: 10.1016/j.josat.2024.209618.

"Catching Chain" With Medicaid: The Impact of Medicaid Access on Opioid Overdose Mortality in Adults Released From State Detention.

Blumberger L, Calo W, Mallinson D, Liu G, Leslie D Psychiatr Res Clin Pract. 2024; 6(3):94-103.

PMID: 39568500 PMC: 11574460. DOI: 10.1176/appi.prcp.20230080.

Disparities in Medication Use for Criminal Justice System-Referred Opioid Use Disorder Treatment.

Donahoe J, Donohue J, Saloner B JAMA Health Forum. 2024; 5(9):e242807.

PMID: 39240579 PMC: 11380100. DOI: 10.1001/jamahealthforum.2024.2807.

Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.

Krawczyk N, Lim S, Cherian T, Goldfeld K, Katyal M, Rivera B Drug Alcohol Depend. 2024; 261:111377.

PMID: 38924958 PMC: 11249039. DOI: 10.1016/j.drugalcdep.2024.111377.

References

Finlay A, Harris A, Rosenthal J, Blue-Howells J, Clark S, McGuire J . Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend. 2016; 160:222-6. PMC: 4767599. DOI: 10.1016/j.drugalcdep.2016.01.013. View

Hedrich D, Alves P, Farrell M, Stover H, Moller L, Mayet S . The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction. 2011; 107(3):501-17. DOI: 10.1111/j.1360-0443.2011.03676.x. View

Bunting A, Oser C, Staton M, Eddens K, Knudsen H . Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach. Addict Sci Clin Pract. 2018; 13(1):23. PMC: 6278109. DOI: 10.1186/s13722-018-0124-2. View

Merrall E, Kariminia A, Binswanger I, Hobbs M, Farrell M, Marsden J . Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010; 105(9):1545-54. PMC: 2955973. DOI: 10.1111/j.1360-0443.2010.02990.x. View

Winkelman T, Chang V, Binswanger I . Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use. JAMA Netw Open. 2019; 1(3):e180558. PMC: 6324297. DOI: 10.1001/jamanetworkopen.2018.0558. View

Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich J . Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009; 105(1-2):83-8. PMC: 2743749. DOI: 10.1016/j.drugalcdep.2009.06.015. View

Brinkley-Rubinstein L, Cloud D, Davis C, Zaller N, Delany-Brumsey A, Pope L . Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings. Int J Prison Health. 2017; 13(1):25-31. DOI: 10.1108/IJPH-08-2016-0039. View

White I, Royston P, Wood A . Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011; 30(4):377-99. DOI: 10.1002/sim.4067. View

Binswanger I, Stern M, Yamashita T, Mueller S, Baggett T, Blatchford P . Clinical risk factors for death after release from prison in Washington State: a nested case-control study. Addiction. 2015; 111(3):499-510. PMC: 4834273. DOI: 10.1111/add.13200. View

10.

Rudd R, Aleshire N, Zibbell J, Gladden R . Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016; 64(50-51):1378-82. DOI: 10.15585/mmwr.mm6450a3. View

11.

Marsden J, Stillwell G, Jones H, Cooper A, Eastwood B, Farrell M . Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction. 2017; 112(8):1408-1418. DOI: 10.1111/add.13779. View

12.

Matusow H, Dickman S, Rich J, Fong C, Dumont D, Hardin C . Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. J Subst Abuse Treat. 2012; 44(5):473-80. PMC: 3602216. DOI: 10.1016/j.jsat.2012.10.004. View

13.

Wakeman S, McKinney M, Rich J . Filling the gap: the importance of Medicaid continuity for former inmates. J Gen Intern Med. 2009; 24(7):860-2. PMC: 2695526. DOI: 10.1007/s11606-009-0977-x. View

14.

Chandler R, Fletcher B, Volkow N . Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009; 301(2):183-90. PMC: 2681083. DOI: 10.1001/jama.2008.976. View

15.

Green T, Clarke J, Brinkley-Rubinstein L, Marshall B, Alexander-Scott N, Boss R . Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System. JAMA Psychiatry. 2018; 75(4):405-407. PMC: 5875331. DOI: 10.1001/jamapsychiatry.2017.4614. View

16.

Slavova S, OBrien D, Creppage K, Dao D, Fondario A, Haile E . Drug Overdose Deaths: Let's Get Specific. Public Health Rep. 2015; 130(4):339-42. PMC: 4547584. DOI: 10.1177/003335491513000411. View

17.

Binswanger I, Stern M, Deyo R, Heagerty P, Cheadle A, Elmore J . Release from prison--a high risk of death for former inmates. N Engl J Med. 2007; 356(2):157-65. PMC: 2836121. DOI: 10.1056/NEJMsa064115. View

18.

Bird S, McAuley A, Perry S, Hunter C . Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addiction. 2015; 111(5):883-91. PMC: 4982071. DOI: 10.1111/add.13265. View

19.

Huxley-Reicher Z, Maldjian L, Winkelstein E, Siegler A, Paone D, Tuazon E . Witnessed overdoses and naloxone use among visitors to Rikers Island jails trained in overdose rescue. Addict Behav. 2017; 86:73-78. DOI: 10.1016/j.addbeh.2017.11.029. View

20.

Kim S, Ting A, Puisis M, Rodriguez S, Benson R, Mennella C . Deaths in the Cook County jail: 10-year report, 1995-2004. J Urban Health. 2006; 84(1):70-84. PMC: 2078256. DOI: 10.1007/s11524-006-9115-9. View